AVDL
Avadel Pharmaceuticals plc
NASDAQHealthcareDrug Manufacturers - Specialty & GenericIE
Company Profile
CEO
Gregory J. Divis Jr.
IPO Date
1996-06-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
IE
Avadel Pharmaceuticals plc
CEO
Gregory J. Divis Jr.
IPO Date
1996-06-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
IE
| 0 |
| $0.00 |
| 12 Feb 2026 | Rodriguez Susan | Chief Operating Officer | D-Return | Disposed | 300,000 | $9.59 |
| 12 Feb 2026 | Thornton Peter J. | director | D-Return | Disposed | 42,000 | $8.07 |
| 12 Feb 2026 | Thornton Peter J. | director | D-Return | Disposed | 42,000 | $4.79 |
| 12 Feb 2026 | Thornton Peter J. | director | D-Return | Disposed | 11,000 | $10.83 |
| 12 Feb 2026 | Thornton Peter J. | director | D-Return | Disposed | 42,000 | $8.48 |
| 12 Feb 2026 | Thornton Peter J. | director | D-Return | Disposed | 115,060 | $21.00 |
| 12 Feb 2026 | Thornton Peter J. | director | D-Return | Disposed | 60,000 | $2.03 |
| 12 Feb 2026 | Thornton Peter J. | director | D-Return | Disposed | 33,000 | $14.10 |